by Russ Ward (@russcward)
What does it feel like to have a heart attack? What’s the cure for muscle soreness post-workout? What one daily habit has the most positive effect on your health?
These are real questions asked on the popular question and answer site Quora. Question sites such as Quora, Yahoo! Answers, and Fluther are proliferating [...]
Tags:Compliance·crowdsource·digital strategy·Digital Tools·Education·healthcare·metrics·Patients·Pharma·Pharmaceutical industry·regulations·social media metrics
By Sven Larsen (@zemoga)
In the weeks following ad:tech New York, the song above was stuck in my head. Why? In between sessions, I was reading my free copy of Fast Company from the attendee gift bag, which included a feature about the popular Disney Channel cartoon, Phineas & Ferb. I had combed through most of [...]
Tags:cartoon·community·DDMAC·demographic·Disney·doctors·e-patients·faith·FDA·fearless·guidance·industry·Pharma·Phineas & Ferb·regulations·social media·television·Thomas Abrams
By Jon Fisher (@jmfisher)
Is e-mail destined to go the way of postal mail? While e-mail is nearly ubiquitous and remains a popular form of communication among business users, speculation that new messaging platforms will be an “e-mail killer” is percolating.
Older generations of workers are likely to rely on e-mail as their main form of communication, [...]
Tags:brand·business·chat·communication·Compliance·e-mail·equity·Facebook·management·messaging·network·organize·Pharma industry·regulations·silo·technology·time-sensitive·Web
This post wraps up our week-long discussion around the topic “What Would the Government Regulate?”
By Jason Brandt (@Jasondmg3)
Last month, Pixels & Pills’ Jennifer Abelson interviewed Steve Woodruff of Impactiviti at the ePharma Summit.
Apart from how utterly TV-presenter smooth both of their voices are – we’re lucky they got into pharma before they were snapped up [...]
Tags:advertising·communication·digital strategy·Facebook·FDA·innovation·Legal Issues·marketing·Pharmaceutical industry·regulations·social media·technology·Trends·Twitter
New Changes for Facebook, New Perspective for Pharma
April 15th, 2011 · 7 Comments · News
UPDATE 4/20/2011: As of the publish date of this post, none of the information contained here has been confirmed by any official sources, either direct from Facebook or any leading media authorities on Facebook development. I have consulted the individuals and organizations cited below for the origins of this information, and will notify the Pixels [...]
[Read more →]
Tags:adverse events·approval·brand·changes·comment·content·conversation·disable·discrtion·discussion·drug·Facebook·industry·initiatives·Pharma·photos·policy·prescription·regulations·sharing·social media·strategy·user generated content·videos·vigilance·wall·whitelisting